日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/09/22 | 6,295 | 6,381 | 6,270 | 6,335 | -23 | -0.4% | 366,500 |
| 2023/09/21 | 6,480 | 6,480 | 6,344 | 6,358 | -145 | -2.2% | 292,800 |
| 2023/09/20 | 6,605 | 6,674 | 6,501 | 6,503 | -144 | -2.2% | 370,400 |
| 2023/09/19 | 6,627 | 6,750 | 6,604 | 6,647 | +6 | +0.1% | 416,800 |
| 2023/09/15 | 6,560 | 6,650 | 6,545 | 6,641 | +29 | +0.4% | 356,700 |
| 2023/09/14 | 6,630 | 6,698 | 6,585 | 6,612 | +11 | +0.2% | 304,700 |
| 2023/09/13 | 6,682 | 6,682 | 6,579 | 6,601 | -46 | -0.7% | 244,000 |
| 2023/09/12 | 6,468 | 6,662 | 6,447 | 6,647 | +183 | +2.8% | 388,200 |
| 2023/09/11 | 6,537 | 6,568 | 6,415 | 6,464 | -85 | -1.3% | 331,200 |
| 2023/09/08 | 6,649 | 6,784 | 6,533 | 6,549 | -76 | -1.1% | 762,500 |
| 2023/09/07 | 6,512 | 6,686 | 6,491 | 6,625 | +149 | +2.3% | 714,400 |
| 2023/09/06 | 6,430 | 6,606 | 6,374 | 6,476 | +146 | +2.3% | 871,000 |
| 2023/09/05 | 6,376 | 6,430 | 6,287 | 6,330 | -107 | -1.7% | 425,800 |
| 2023/09/04 | 6,484 | 6,484 | 6,355 | 6,437 | -17 | -0.3% | 365,900 |
| 2023/09/01 | 6,376 | 6,516 | 6,356 | 6,454 | +55 | +0.9% | 597,200 |
| 2023/08/31 | 6,223 | 6,406 | 6,222 | 6,399 | +128 | +2% | 4,589,700 |
| 2023/08/30 | 6,250 | 6,331 | 6,225 | 6,271 | +32 | +0.5% | 560,000 |
| 2023/08/29 | 6,251 | 6,261 | 6,147 | 6,239 | -15 | -0.2% | 592,500 |
| 2023/08/28 | 6,260 | 6,296 | 6,155 | 6,254 | +30 | +0.5% | 541,900 |
| 2023/08/25 | 6,093 | 6,244 | 6,055 | 6,224 | +37 | +0.6% | 603,800 |
| 2023/08/24 | 6,170 | 6,220 | 6,131 | 6,187 | +16 | +0.3% | 460,400 |
| 2023/08/23 | 6,204 | 6,210 | 6,053 | 6,171 | -48 | -0.8% | 557,200 |
| 2023/08/22 | 6,116 | 6,221 | 6,104 | 6,219 | +150 | +2.5% | 645,000 |
| 2023/08/21 | 5,900 | 6,088 | 5,895 | 6,069 | +250 | +4.3% | 547,200 |
| 2023/08/18 | 5,714 | 5,832 | 5,651 | 5,819 | +105 | +1.8% | 411,100 |
| 2023/08/17 | 5,796 | 5,799 | 5,663 | 5,714 | -113 | -1.9% | 372,500 |
| 2023/08/16 | 5,820 | 5,875 | 5,765 | 5,827 | -58 | -1% | 477,300 |
| 2023/08/15 | 5,918 | 5,977 | 5,780 | 5,885 | -69 | -1.2% | 598,700 |
| 2023/08/14 | 6,037 | 6,299 | 5,934 | 5,954 | -15 | -0.3% | 1,013,200 |
| 2023/08/10 | 5,850 | 5,970 | 5,850 | 5,969 | +39 | +0.7% | 430,000 |
| 2023/08/09 | 5,824 | 5,949 | 5,785 | 5,930 | +155 | +2.7% | 578,900 |
| 2023/08/08 | 5,752 | 5,790 | 5,732 | 5,775 | +21 | +0.4% | 312,100 |
| 2023/08/07 | 5,653 | 5,754 | 5,641 | 5,754 | +78 | +1.4% | 306,000 |
| 2023/08/04 | 5,696 | 5,706 | 5,648 | 5,676 | -66 | -1.1% | 320,200 |
| 2023/08/03 | 5,774 | 5,776 | 5,679 | 5,742 | -44 | -0.8% | 365,600 |
| 2023/08/02 | 5,774 | 5,820 | 5,763 | 5,786 | -33 | -0.6% | 445,900 |
| 2023/08/01 | 5,761 | 5,819 | 5,734 | 5,819 | +65 | +1.1% | 397,300 |
| 2023/07/31 | 5,776 | 5,788 | 5,722 | 5,754 | +20 | +0.3% | 305,400 |
| 2023/07/28 | 5,650 | 5,752 | 5,603 | 5,734 | +54 | +1% | 412,800 |
| 2023/07/27 | 5,693 | 5,703 | 5,607 | 5,680 | -50 | -0.9% | 403,500 |
| 2023/07/26 | 5,696 | 5,745 | 5,686 | 5,730 | +50 | +0.9% | 377,800 |
| 2023/07/25 | 5,721 | 5,730 | 5,654 | 5,680 | -69 | -1.2% | 498,600 |
| 2023/07/24 | 5,676 | 5,749 | 5,639 | 5,749 | +144 | +2.6% | 490,500 |
| 2023/07/21 | 5,589 | 5,610 | 5,545 | 5,605 | +115 | +2.1% | 385,000 |
| 2023/07/20 | 5,536 | 5,546 | 5,484 | 5,490 | -36 | -0.7% | 338,300 |
| 2023/07/19 | 5,501 | 5,526 | 5,464 | 5,526 | +47 | +0.9% | 514,400 |
| 2023/07/18 | 5,460 | 5,550 | 5,427 | 5,479 | +36 | +0.7% | 394,700 |
| 2023/07/14 | 5,406 | 5,463 | 5,392 | 5,443 | +1 | ±0% | 338,500 |
| 2023/07/13 | 5,390 | 5,450 | 5,351 | 5,442 | +50 | +0.9% | 342,400 |
| 2023/07/12 | 5,389 | 5,413 | 5,340 | 5,392 | +6 | +0.1% | 366,500 |
151～
200
件表示中 / 3450件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 442,800円 | +2.0% | +11.5% | 2.80% | 11.47倍 | 1.41倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 参天薬 | 154,600円 | +8.2% | - | 2.13% | 19.03倍 | 1.83倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| 久光薬 | 384,100円 | +7.3% | -3.8% | 2.34% | 18.41倍 | 1.10倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ツムラ | 368,600円 | +8.5% | -4.5% | 1.90% | 17.28倍 | 1.06倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| ペプチド | 197,800円 | +21.9% | +134.3% | 0.00% | 35.12倍 | 6.35倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
